Sejong Medical Past Earnings Performance
Past criteria checks 0/6
Sejong Medical's earnings have been declining at an average annual rate of -94%, while the Medical Equipment industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 3% per year.
Key information
-94.0%
Earnings growth rate
-88.8%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 3.0% |
Return on equity | n/a |
Net Margin | -374.9% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively
Mar 24Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year
Mar 02Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?
Feb 11We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability
Jan 27Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?
Jan 12Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon
Dec 25Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?
Dec 23These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well
Dec 08The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More
Nov 19Revenue & Expenses Breakdown
How Sejong Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 19,101 | -71,605 | 8,639 | 1,175 |
31 Dec 23 | 17,992 | -23,087 | 7,817 | 880 |
31 Dec 22 | 16,083 | -91,366 | 6,983 | 1,473 |
30 Sep 22 | 16,931 | -5,411 | 9,412 | 1,294 |
30 Jun 22 | 13,361 | -5,375 | 6,882 | 771 |
31 Mar 22 | 17,759 | -6,111 | 8,705 | 1,275 |
31 Dec 21 | 18,021 | -5,192 | 8,145 | 1,528 |
30 Sep 21 | 17,703 | -1,762 | 6,183 | 2,103 |
30 Jun 21 | 17,079 | -985 | 6,057 | 2,174 |
31 Mar 21 | 15,881 | -64 | 5,430 | 2,232 |
31 Dec 20 | 15,098 | 470 | 5,297 | 2,127 |
30 Sep 20 | 15,465 | 1,682 | 5,369 | 1,693 |
30 Jun 20 | 15,238 | 2,668 | 4,613 | 1,435 |
31 Mar 20 | 15,829 | 3,173 | 4,570 | 1,166 |
31 Dec 19 | 16,230 | 3,464 | 4,542 | 1,057 |
30 Sep 19 | 15,924 | 3,636 | 4,371 | 1,295 |
30 Jun 19 | 15,927 | 3,942 | 4,297 | 1,246 |
31 Mar 19 | 15,309 | 3,695 | 4,387 | 1,228 |
31 Dec 18 | 14,833 | 3,787 | 4,113 | 1,202 |
30 Sep 18 | 13,622 | 2,315 | 4,342 | 1,200 |
30 Jun 18 | 14,102 | 2,516 | 4,367 | 1,140 |
31 Mar 18 | 14,473 | 3,167 | 3,962 | 1,063 |
31 Dec 17 | 14,550 | 3,214 | 3,912 | 987 |
31 Dec 16 | 12,773 | 3,169 | 3,075 | 916 |
31 Dec 15 | 11,957 | 1,550 | 2,996 | 1,006 |
Quality Earnings: A258830 is currently unprofitable.
Growing Profit Margin: A258830 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A258830 is unprofitable, and losses have increased over the past 5 years at a rate of 94% per year.
Accelerating Growth: Unable to compare A258830's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A258830 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.1%).
Return on Equity
High ROE: A258830's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/06/26 03:21 |
End of Day Share Price | 2024/03/29 00:00 |
Earnings | 2024/03/31 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sejong Medical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|